Prise en charge du paludisme grave d’importation de l’adulte

  title={Prise en charge du paludisme grave d’importation de l’adulte},
  author={Fabrice Bruneel and Alexandra Raffetin and A. Roujansky and Philippe Corne and Christian Tridon and J.-F. Llitjos and Bruno Mourvillier and Virginie Laurent and St{\'e}phane Jaur{\'e}guiberry},
En France, le paludisme grave d’importation concerne environ 12 a 14 % des acces palustres et implique tres majoritairement Plasmodium falciparum . A partir de la definition du paludisme grave de l’Organisation mondiale de la sante utilisee en zone d’endemie palustre, la definition francaise du paludisme grave d’importation de l’adulte a ete adaptee aux donnees et au contexte europeens. La prise en charge du paludisme grave est une urgence diagnostique et therapeutique qui doit etre realisee… 
1 Citations
Infections tropicales graves dans les départements français d’Amérique, Antilles françaises et Guyane
Les Antilles-Guyane (AG) sont les départements français du continent américain, situés en zone intertropicale. La diversité des écosystèmes ainsi que le climat tropical à très forte pluviosité


Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis
This study provides further evidence on delayed haemolysis after artesunate and underlines the importance of a standardized follow-up of patients treated with artes unate for severe malaria.
Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications
The frequency of PADH supports the need of weekly follow-up of haematological parameters during 1 month and full GMP qualification for the drug and rapid approval by drug agencies is warranted, backed by clear recommendations for optimal use.
The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study
During imported malaria, the most useful biomarkersassociated with severity seem to be plasma albumin and sTREM-1; and among parasite-related parameters, PfHRP2 was more strongly associated with severity than parasitemia was.
Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy?
Artemisinin monotherapy may offer rapid recovery and fast parasite clearance, but recrudescence is frequent; extending the duration of monotherapy from 5 days to 7 days does not reduce recrUDescence.
Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data.
Evidence that falciparum malaria is more serious in older patients is provided and clinical surveillance networks are capable of providing quality data for investigation of rare events or diseases is demonstrated.
Management of imported malaria in Europe
In this position paper, the European Society for Clinical Microbiology and Infectious Diseases, Study Group on Clinical Parasitology, summarizes main issues regarding the management of imported
Severe malaria in Europe: an 8-year multi-centre observational study
Intravenous artesunate is increasingly used for treatment of severe malaria in many European treatment centres and can be given safely to European patients with severe malaria.
Severe Imported Plasmodium falciparum Malaria, France, 1996–2003
Factors independently associated with severe imported P. falciparum malaria were older age, European origin, travel to eastern Africa, absence of chemoprophylaxis, initial visit to a general practitioner, time to diagnosis of 4 to 12 days, and diagnosis during the fall-winter season.
Spread of artemisinin resistance in Plasmodium falciparum malaria.
Prolonged courses of artemisinin-based combination therapies are currently efficacious in areas where standard 3-day treatments are failing, and the incidence of pretreatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission.